Acute lymphoblastic leukemia (supportive therapy after bone marrow transplantation)
Acute lymphoblastic leukemia (supportive therapy after bone marrow transplantation) is a set of measures aimed at maintaining the patient’s condition during donor cell engraftment, preventing and managing complications, and avoiding relapse.
Submit a request to find out the price
Fill applicationAcute lymphoblastic leukemia (supportive therapy after bone marrow transplantation)
Acute lymphoblastic leukemia (supportive therapy after bone marrow transplantation) is a set of measures aimed at maintaining the patient’s condition during donor cell engraftment, preventing and managing complications, and avoiding relapse.
Acute lymphoblastic leukemia (supportive therapy after bone marrow transplantation) is a set of measures aimed at maintaining the patient’s condition during donor cell engraftment, preventing and managing complications, and avoiding relapse. The stem cell transplant is only the first step, while the real treatment begins after the donor cells have entered the bloodstream. At this stage, the patient’s immune system is almost completely suppressed, while the new, donor-derived immune system has not yet become active. The goal of supportive therapy is to provide comprehensive protection until the balance is restored.
Choose where to be treated
Select one of the hospitals providing the service:
Which doctor do you want to be treated by?
Select one of the doctors
